News & Updates
Showing Multidisciplinary articles
Showing

PORTEC-3: Adjuvant chemoradiotherapy improves 10-year OS in high-risk endometrial cancer
Adjuvant chemoradiotherapy (CRT) improves both 10-year overall survival (OS) and recurrence-free survival (RFS) in women with high-risk endometrial cancer vs pelvic radiotherapy alone, with the most clinically relevant benefit observed in p53 abnormal cancers, according to the 10-year analysis of the phase III PORTEC-3 trial.
PORTEC-3: Adjuvant chemoradiotherapy improves 10-year OS in high-risk endometrial cancer
15 Sep 2025
Reduced apical rotation linked to functional mitral regurgitation after ST-elevation MI
A significant association exists between a reduced apical rotation and functional mitral regurgitation in patients with acute ST-elevation myocardial infarction (MI), suggesting a potential novel pathophysiological mechanism, reports a study.
Reduced apical rotation linked to functional mitral regurgitation after ST-elevation MI
14 Sep 2025
Enzalutamide plus radium-223 improves rPFS in mCRPC
First-line treatment with enzalutamide plus radium-223 (Ra223) results in significant improvements in radiological progression-free survival (rPFS) in patients with metastatic castration-resistant prostate cancer (mCRPC), results of the EORTC 1222/PEACE-3 trial have shown.






